Connect with us


VLCC announces JV with Korean company ‘Caregen’ to introduce age defying technology



Premium wellness brand VLCC Health Care Ltd. and Korea’s leading biotechnology and R&D company, Caregen Co.,Ltd. today announced a joint venture for selling Caregen’s range of cosmeceutical brands such as Dermaheal, RENOKIN, and DR.CYJ that provide cutting-edge anti-ageing solutions in 25 countries in Asia, North Africa and East Africa*. The business will be run under a JV Company named VLCC Caregen Pvt. Ltd with 50:50 stake, which also has exclusive rights in India and few other countries.

Caregen will also work with VLCC’s R&D team to conduct studies on various new products and innovations while also providing technical support for clinical trials, if required. Under the agreement, VLCC and Caregen will also share technological resources should they decide to use VLCC’s manufacturing facilities.  In that case, VLCC will manufacture the products to sell them at competitive prices in the respective countries.

Through this partnership, VLCC and Caregen will deliver to the beauty and wellness industry in India, highly innovative and efficacious solutions that are gaining popularity globally.

“Korean people demand perfection, especially when it comes to skincare products, driving innovation in the industry.  With our tie-up with Caregen, we are bringing the best of Korean technology to our customers” said Mr. Mukesh Luthra, Chairman, VLCC Group. “Caregen’s products and solutions will complement and enhance our existing portfolio, which comprises of products from India, Malaysia, Singapore and Switzerland.” 

Korean skincare products are fast-rising in popularity globally owing to their consistent investments in R&D. Deep-rooted in skincare treatment rituals; Korea provides high-end technology at highly competitive prices. “Every marketer who is looking at expanding their portfolio of high-performance products, will sooner or later turn to Korea”, Mr. Luthra added.

“We are very proud to be partnering with VLCC. The company is a respected multinational with 25 years of experience in the industry and this collaboration will open up a whole new market for us,” said Mr. Yongji Chung, CEO, Caregen Co., Ltd.

Caregen’s Dermaheal brand makes high quality cosmeceutical products which contain its state-of-the-art growth factors and biomimetic peptides. Dermaheal products take care of anti-ageing, anti-pigmentation, anti-hair loss and hair regrowth, anti-inflammation and other skin troubles with homecare and professional care lines.

Caregen’s top selling products which VLCC will be introducing in the Indian market include: Dermaheal Eye Filler Mask, a high concentration of active ingredients which hydrates and soothes the sensitive skin around the eyes while helping it look younger, RENOKIN Hair Revitalizing Program, a scientific haircare program proven by the sophisticated mechanism of active ingredients and human clinical tests. Its ten active ingredients include the world’s strongest and safest hair re-growth activators, CG-Nokkin, CG-Keramin2 and CG-WINT, and DR. CYJ Hair exCell Serum, a professional and specialized peptide complex for hair re-growth and scalp reconstruction treatment with guaranteed results.

These will be incorporated in VLCC’s beauty therapies and will also be distributed through the company’s wellness centres.

*Asia (India, Bangladesh & Nepal), Israel, North Africa (Algeria, Libya, Sudan, Tunisia, Western Sahara) and East Africa (Comoros, Kenya, Madagascar, Malawi, Mauritius, Mayotte (France), Mozambique, Reunion (France), Rwanda, Seychelles, South Sudan, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria).



Continue Reading